These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3342880)

  • 1. Cell attachment and fibrinogen binding properties of platelet and endothelial cell thrombospondin are not affected by structural differences in the 70 and 18 kDa protease-resistant domains.
    Clezardin P; Bourdillon MC; Hunter NR; McGregor JL
    FEBS Lett; 1988 Feb; 228(2):215-8. PubMed ID: 3342880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts. Evidence for a thrombospondin polymorphism.
    Clezardin P; Hunter NR; Lawler JW; Pratt DA; McGregor JL; Pepper DS; Dawes J
    Eur J Biochem; 1986 Sep; 159(3):569-79. PubMed ID: 3758079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of endothelial cell thrombospondin. Characterization of the heparin-binding domains.
    Dardik R; Lahav J
    Eur J Biochem; 1987 Oct; 168(2):347-55. PubMed ID: 2822410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin interaction with fibrinogen. Evidence for binding to the A alpha- and B beta-chains of fibrinogen.
    Bacon-Baguley T; Kudryk BJ; Walz DA
    J Biol Chem; 1987 Feb; 262(5):1927-30. PubMed ID: 3818582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of the fibrinogen-binding region of platelet thrombospondin.
    Dixit VM; Grant GA; Frazier WA; Santoro SA
    Biochem Biophys Res Commun; 1984 Mar; 119(3):1075-81. PubMed ID: 6712666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex formation of platelet thrombospondin with fibrinogen.
    Leung LL; Nachman RL
    J Clin Invest; 1982 Sep; 70(3):542-9. PubMed ID: 6213638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and immunological differences between human platelet and endothelial thrombospondins.
    Clezardin P; Hunter NR; McGregor JL; Pepper DS; Dawes J
    FEBS Lett; 1986 Feb; 196(1):49-53. PubMed ID: 3943631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the platelet agglutinating activity of thrombospondin.
    Haverstick DM; Dixit VM; Grant GA; Frazier WA; Santoro SA
    Biochemistry; 1985 Jun; 24(13):3128-34. PubMed ID: 4027236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple domains are involved in the interaction of endothelial cell thrombospondin with fibronectin.
    Dardik R; Lahav J
    Eur J Biochem; 1989 Nov; 185(3):581-8. PubMed ID: 2512126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding.
    Lahav J; Lawler J; Gimbrone MA
    Eur J Biochem; 1984 Nov; 145(1):151-6. PubMed ID: 6489349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction.
    Tuszynski GP; Srivastava S; Switalska HI; Holt JC; Cierniewski CS; Niewiarowski S
    J Biol Chem; 1985 Oct; 260(22):12240-5. PubMed ID: 3930491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin.
    Clezardin P; McGregor JL; Lyon M; Clemetson KJ; Huppert J
    Eur J Biochem; 1986 Jan; 154(1):95-102. PubMed ID: 2417838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.
    Nachman RL; Leung LL
    J Clin Invest; 1982 Feb; 69(2):263-9. PubMed ID: 6460044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex formation of human thrombospondin with osteonectin.
    Clezardin P; Malaval L; Ehrensperger AS; Delmas PD; Dechavanne M; McGregor JL
    Eur J Biochem; 1988 Aug; 175(2):275-84. PubMed ID: 3402455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
    Dardik R; Lahav J
    Biochemistry; 1991 Sep; 30(38):9378-86. PubMed ID: 1716458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin.
    McPherson J; Sage H; Bornstein P
    J Biol Chem; 1981 Nov; 256(21):11330-6. PubMed ID: 7287769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin binds to amino-terminal fragments of plasma fibronectin.
    Homandberg GA; Kramer-Bjerke J
    Thromb Res; 1987 Nov; 48(3):329-35. PubMed ID: 3433257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
    Lawler J; Weinstein R; Hynes RO
    J Cell Biol; 1988 Dec; 107(6 Pt 1):2351-61. PubMed ID: 2848850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet thrombospondin mediates attachment and spreading of human melanoma cells.
    Roberts DD; Sherwood JA; Ginsburg V
    J Cell Biol; 1987 Jan; 104(1):131-9. PubMed ID: 3793757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.